N-(2,5-Dimethylphenyl)-2-((3-ethyl-6-methyl-4-oxo-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)acetamide

Catalog No. :
ACOCBO144
CAS No. :
851409-40-0
Molecular Formula :
C19H23N3O2S2
Molecular Weight :
389.55

IUPAC Name:N-(2,5-dimethylphenyl)-2-((3-ethyl-6-methyl-4-oxo-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)acetamide

N-(2,5-Dimethylphenyl)-2-((3-ethyl-6-methyl-4-oxo-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2,5-Dimethylphenyl)-2-((3-ethyl-6-methyl-4-oxo-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)acetamide
IUPAC NameN-(2,5-dimethylphenyl)-2-((3-ethyl-6-methyl-4-oxo-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)acetamide
Molecular FormulaC19H23N3O2S2
Molecular Weight389.55
SMILESCCN1C(C2=C(N=C1SCC(NC3=C(C)C=CC(C)=C3)=O)CC(C)S2)=O
InChI KeyGGZJQADAVIYZCZ-UHFFFAOYSA-N
SynonymN-(2,5-dimethylphenyl)-2-((3-ethyl-6-methyl-4-oxo-3,4,6,7-tetrahydrothieno[3,2-d]pyrimidin-2-yl)thio)acetamide;Acetamide, N-(2,5-dimethylphenyl)-2-[(3-ethyl-3,4,6,7-tetrahydro-6-methyl-4-oxothieno[3,2-d]pyrimidin-2-yl)thio]-
CAS No.851409-40-0

Synthetic Route by SureRoute

1. ACOCBO144 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDRSM912 route compound structure diagram
    ACDRSM91251786-53-9 In Stock
  4. Then
  5. ACOCBO144 route product structure diagram
    ACOCBO144851409-40-0
Inquiry

2. ACOCBO144 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOCBO144 route product structure diagram
    ACOCBO144851409-40-0
Inquiry

Comments (0)